N-(5-bromo-3-pyridinyl)-5-(4-chlorophenyl)-3-cyclobutyliminophenazin-2-amine
C27H21BrClN5 — CID 66805881
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(5-bromo-3-pyridinyl)-5-(4-chlorophenyl)-3-cyclobutyliminophenazin-2-amine
N-(5-bromo-3-pyridinyl)-5-(4-chlorophenyl)-3-cyclobutyliminophenazin-2-amine (PubChem CID 66805881) has the molecular formula C27H21BrClN5 and a molecular weight of 530.86 g/mol. Its IUPAC name is N-(5-bromo-3-pyridinyl)-5-(4-chlorophenyl)-3-cyclobutyliminophenazin-2-amine.
Molecular Properties
| Compound Name | N-(5-bromo-3-pyridinyl)-5-(4-chlorophenyl)-3-cyclobutyliminophenazin-2-amine |
|---|---|
| PubChem CID | 66805881 |
| Molecular Formula | C27H21BrClN5 |
| Molecular Weight | 530.86 g/mol |
| Exact Mass | 529.07 |
| IUPAC Name | N-(5-bromo-3-pyridinyl)-5-(4-chlorophenyl)-3-cyclobutyliminophenazin-2-amine |
| SMILES | Clc1ccc(-n2c3c/c(=N\C4CCC4)c(Nc4cncc(Br)c4)cc-3nc3ccccc32)cc1 |
| InChI | InChI=1S/C27H21BrClN5/c28-17-12-20(16-30-15-17)32-23-13-25-27(14-24(23)31-19-4-3-5-19)34(21-10-8-18(29)9-11-21)26-7-2-1-6-22(26)33-25/h1-2,6-16,19,32H,3-5H2/b31-24+ |
| InChIKey | XXKMHVYJCZWMIZ-QFMPWRQOSA-N |
| XLogP | 7.14 |
| TPSA | 55.10 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 530.86 |
| LogP ≤ 5 | 7.14 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Polycyclic_aromatic_hydrocarbon_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 66805881 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.